Nordea Investment Management AB Grows Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nordea Investment Management AB raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 43,200 shares of the medical equipment provider’s stock after buying an additional 10,405 shares during the quarter. Nordea Investment Management AB’s holdings in Intuitive Surgical were worth $22,632,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the company. Mirador Capital Partners LP lifted its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the period. Exome Asset Management LLC lifted its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Consolidated Planning Corp boosted its stake in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after acquiring an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in Intuitive Surgical by 617.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares in the last quarter. Finally, Swiss National Bank raised its holdings in Intuitive Surgical by 0.3% during the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after purchasing an additional 3,400 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $544.02 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $325.77 and a 12 month high of $556.23. The stock’s 50-day moving average is $534.30 and its two-hundred day moving average is $493.26. The stock has a market cap of $193.77 billion, a PE ratio of 87.46, a P/E/G ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ISRG shares. Robert W. Baird raised their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. BTIG Research lifted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Mizuho boosted their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.